Canada Life
BEAM icon

Canada Life’s Beam Therapeutics BEAM Stock Holding History

Canada Life’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$588K Buy
24,591
+3,820
+18% +$106K ﹤0.01% 1469
2025
Q4 		$576K Sell
20,771
-8,991
-30% -$229K ﹤0.01% 1482
2025
Q3 		$711K Buy
29,762
+1,602
+6% +$31.9K ﹤0.01% 1528
2025
Q2 		$480K Buy
28,160
+19,265
+217% +$335K ﹤0.01% 1615
2025
Q1 		$174K Buy
8,895
+362
+4% +$9.48K ﹤0.01% 1731
2024
Q4 		$212K Sell
8,533
-641
-7% -$16.4K ﹤0.01% 1740
2024
Q3 		$225K Buy
9,174
+344
+4% +$8.89K ﹤0.01% 1779
2024
Q2 		$207K Buy
8,830
+1,005
+13% +$24.7K ﹤0.01% 1808
2024
Q1 		$259K Buy
7,825
+396
+5% +$12.3K ﹤0.01% 1793
2023
Q4 		$200K Buy
7,429
+1,039
+16% +$25.8K ﹤0.01% 1842
2023
Q3 		$154K Buy
6,390
+3,000
+88% +$80.4K ﹤0.01% 1893
2023
Q2 		$109K Buy
3,390
+201
+6% +$6.52K ﹤0.01% 1915
2023
Q1 		$98K Sell
3,189
-245
-7% -$9.67K ﹤0.01% 1983
2022
Q4 		$136K Buy
3,434
+467
+16% +$20.9K ﹤0.01% 1932
2022
Q3 		$142K Buy
2,967
+74
+3% +$4.22K ﹤0.01% 1930
2022
Q2 		$112K Buy
2,893
+1,065
+58% +$42.3K ﹤0.01% 1899
2022
Q1 		$112K Buy
1,828
+66
+4% +$4.33K ﹤0.01% 1967
2021
Q4 		$140K Buy
1,762
+63
+4% +$5.39K ﹤0.01% 1938
2021
Q3 		$149K Hold
1,699
– – ﹤0.01% 1969
2021
Q2 		$218K Buy
1,699
+658
+63% +$52.4K ﹤0.01% 1909
2021
Q1 		$83K Sell
1,041
-365
-26% -$34.7K ﹤0.01% 2150
2020
Q4 		$114K Hold
1,406
– – ﹤0.01% 2084
2020
Q3 		$35K Hold
1,406
– – ﹤0.01% 2269
2020
Q2 		$39K Buy
+1,406
New +$30.3K ﹤0.01% 2300

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Canada Life's BEAM Position: Q1 2026 in Review

Canada Life increased its Beam Therapeutics (BEAM) stake by 18% in Q1 2026, buying an estimated $106K and bringing the position to 24,591 shares worth $588K. The position accounts for ﹤0.01% of the portfolio, ranked #1469.

Canada Life first reported a position in BEAM in Q2 2020 and has held it in 24 quarters since. The position peaked at $711K in Q3 2025. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Canada Life held 24,591 shares of Beam Therapeutics worth $588K as of Q1 2026.
  • Canada Life bought 3,820 Beam Therapeutics shares in Q1 2026, an estimated $106K.
  • Beam Therapeutics made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1469 holding.
  • Canada Life first reported a position in Beam Therapeutics in Q2 2020 and has held it in 24 quarters since.
  • Canada Life's Beam Therapeutics position peaked at $711K in Q3 2025.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.